Their findings provided additional evidence by demonstrating an augmented risk of DNMT3A-CH but a reduced risk of TET2-CH by the TCL1A variant, and they identified an additional 24 germline variant loci predisposing individuals to CH. This evidence concerns the gene DNMT3A and cyclic hematopoiesis.